| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IJROBP.2005.03.051 |
| P698 | PubMed publication ID | 15936158 |
| P50 | author | Gene H. Barnett | Q62066084 |
| P2093 | author name string | Michael A Vogelbaum | |
| Shih-Yuan Lee | |||
| John H Suh | |||
| Richard A Prayson | |||
| Bruce H Cohen | |||
| David M Peereboom | |||
| Glen H J Stevens | |||
| Steven A Toms | |||
| Aimee L Quan | |||
| Susan M Staugaitis | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 695-703 | |
| P577 | publication date | 2005-06-02 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme | |
| P478 | volume | 63 |
| Q27014996 | Case comparison and literature review of glioblastoma: A tale of two tumors |
| Q39700144 | Cetuximab insufficiently inhibits glioma cell growth due to persistent EGFR downstream signaling |
| Q35356484 | Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays. |
| Q37364683 | EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells |
| Q30456087 | EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance |
| Q37665244 | Effect of epidermal growth factor receptor gene polymorphisms on prognosis in glioma patients |
| Q47614764 | Epidermal Growth Factor Receptor Expression Predicts Time and Patterns of Recurrence in Patients with Glioblastoma After Radiotherapy and Temozolomide |
| Q36463850 | Epidermal Growth Factor Receptor Is Related to Poor Survival in Glioblastomas: Single-Institution Experience |
| Q92605048 | Evaluation of serum extracellular vesicles as noninvasive diagnostic markers of glioma |
| Q38601004 | Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil. |
| Q38514222 | Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study |
| Q38079529 | Glioblastoma: approach to treat elderly patients |
| Q33702984 | Glioblastoma: clinical, radiological and biological prognostic factors |
| Q30437740 | Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy |
| Q54376413 | Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme |
| Q33410196 | Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951. |
| Q33311133 | Predictive and prognostic markers in neuro-oncology |
| Q36344757 | Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas |
| Q36696480 | Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study. |
| Q41110170 | Prognostic value of epidermal growth factor receptor amplification and EGFRvIII in glioblastoma: meta-analysis |
| Q35659088 | Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors |
| Q41885614 | Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnostics |
| Q33883849 | Role of receptor tyrosine kinases and their ligands in glioblastoma |
| Q92022386 | Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma |
| Q53258665 | Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines |
Search more.